Clearpoint Neuro Inc (CLPT) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Clearpoint Neuro Inc   (NASDAQ: CLPT)

Clearpoint Neuro Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Clearpoint Neuro Inc in the third quarter 2026?
Clearpoint Neuro Inc recorded a cumulative net loss of $-36 million during 12 months ending in the third quarter 2026, resulting in a negative return on equity (ROE) of -170.24%.

Within the Medical Equipment & Supplies industry 151 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 3691, from total ROE ranking in the second quarter 2026 at 4255.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Equity Change 71.77 % -45.42 % -5.73 % 10.36 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -36 -35 -29 -26 -23
Return On Equity (TTM) -170.24 % -188.09 % -140.96 % -122.17 % -114.28 %
CLPT's Total Ranking # 3691 # 4255 # 3671 # 3656 # 3601
Equity (TTM) in Millions 27 11 19 28 16
Seq. Equity Change 153.03 % -42.81 % -32.76 % 76.52 % -19.6 %
Seq. Net Income Change - - - - -

Back to CLPT Management Effectiveness >> CLPT's 5 Years Annual ROE >> Compare CLPT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 152
Sector # 649
Overall # 3691

Return On Equity Statistics
High Average Low
-31.18 %
-131.4 %
-514.82 %
(Dec 31 2021)   (Jun 30 2017)





CLPT Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 28 25 21 37 49
Y / Y Equity Change 10.36 % 19.91 % -42.6 % -24.39 % 1952.46 %
Net Income in Millions -26 -19 -22 -16 -14
Y / Y Net Income Change - - - - -
Return On Equity -91.15 % -74.5 % -104.33 % -44.55 % -29.54 %

Back to CLPT Management Effectiveness >> CLPT's 5 Years Annual ROE >> Compare CLPT ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CLPT's' Return on Equity at Yahoo Finance
CLPT's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CLPT's Competitors
Subscribers only: Roe for Clearpoint Neuro Inc 's Suppliers
Subscribers only: Return On Equity for CLPT's Customers




Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector ROE

Date modified: 2026-10-29T09:59:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.